January 22, 2024 · Form 4 insider transaction
Bencich John bought 75,000 shares of Oncothyreon Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The options vest one-third on the first anniversary of January 22, 2024 and thereafter in monthly installments over 24 months.